International Flavors & Fragrances Inc.

IFF ·Basic Materials, Chemicals, United States

International Flavors & Fragrances (IFF)

Overview

International Flavors & Fragrances Inc. is an American specialty ingredients company headquartered in New York City, sitting in the Specialty Chemicals industry within the Materials sector. IFF was formed in 1958 through the merger of Polak & Schwarz and van Ameringen-Haebler and has grown, largely through acquisition, into one of the world's largest makers of flavors, fragrances, and biosciences-based ingredients, with creative, sales, and manufacturing operations in roughly 44 countries. The company generated about $10.8 billion in revenue on a trailing-twelve-month basis through mid-2026, employs approximately 21,500 people, and carries a market capitalization of roughly $22 billion as of early September 2026.

What They Do & How They Make Money

IFF is a "business-to-business" ingredients supplier: it does not sell products directly to consumers under its own brand, but instead creates and manufactures the flavor compounds, fragrance compounds, functional ingredients, enzymes, and other specialty inputs that go into everyday consumer products made by other companies — think the specific taste profile in a soft drink or snack, the scent in a perfume or laundry detergent, or the enzyme that helps a probiotic supplement or food product work as intended. Customers are large consumer packaged goods companies (food and beverage makers, personal care and home care companies) who pay IFF to develop proprietary formulations tailored to their products, then pay ongoing per-unit prices as those formulations are manufactured and shipped at scale. IFF's competitive value comes from deep R&D and formulation expertise — replicating natural scents and tastes precisely, engineering functional ingredients like enzymes and cultures, and helping customers meet clean-label, sustainability, or cost targets — which makes it a long-term formulation partner rather than a commodity supplier.

Business Segments

Following a series of divestitures that streamlined the company's portfolio (including the sale of its Pharma Solutions business to Roquette for $2.85 billion in 2024, the earlier sale of its Savory Solutions/Flavors business, and the sale of Lucas Meyer Cosmetics), IFF now reports through four core segments:

Taste — Develops and manufactures flavor compounds and ingredients for savory foods (soups, sauces, meat flavorings), beverages (juices, carbonated drinks, spirits), sweets (bakery, candy, cereal), dairy, and spices/seasonings. FY2025 revenue was about $2.48 billion.
Food Ingredients — Supplies natural and plant-based specialty ingredients, natural antioxidants and anti-microbials for food preservation, and protein/emulsifier/sweetener formulations. FY2025 revenue was the largest segment at about $3.28 billion (note: in more recent TTM reporting IFF has folded some Food Ingredients reporting together with other lines, so the segment split shifts somewhat between periods).
Health & Biosciences — Provides enzymes, food cultures, probiotics, and specialty ingredients used across food, home care, animal nutrition, and grain-processing applications — largely inherited from the 2021 merger with DuPont's Nutrition & Biosciences business. FY2025 revenue was about $2.28 billion.
Scent — Creates fragrance compounds and fragrance ingredients for fine fragrances, personal care, and household products, drawing on IFF's long history in perfumery (including proprietary technology for replicating natural floral scents). FY2025 revenue was about $2.48 billion.

IFF's 2025 total revenue also included roughly $369 million from its former Pharma Solutions segment prior to that business's divestiture. Across the go-forward four segments, revenue is fairly evenly distributed, with Food Ingredients somewhat the largest and Health & Biosciences somewhat the smallest.

Competitors

Direct flavor/fragrance rivals: Givaudan (Swiss, the global market leader) and dsm-firmenich (formed from the 2023 merger of DSM and Firmenich) are IFF's closest direct competitors across both taste and scent; both compete head-to-head with IFF for the same large consumer-goods customers and have faced joint antitrust scrutiny alongside IFF (for example, a fragrance-industry antitrust investigation by Indian authorities covering Givaudan, Firmenich, and IFF).
Other flavor/fragrance and ingredients competitors: Symrise (Germany) and Sensient Technologies compete in flavors, fragrances, and specialty ingredients.
Biosciences/enzymes: Novozymes (part of Novonesis following its 2023 merger with Chr. Hansen) is a major rival in enzymes, cultures, and biosciences-based ingredients, an area central to IFF's Health & Biosciences segment.

Competitive Position

IFF's moat rests on decades of proprietary formulation know-how, deep R&D infrastructure (including dedicated research facilities and long-standing scientific partnerships, such as with the Monell Chemical Senses Center), and embedded relationships with large consumer-goods customers who rely on IFF to reformulate products as consumer tastes, regulations, and input costs change — switching a flavor or fragrance supplier can be costly and risky for a customer's product consistency, which creates real stickiness. The 2018 Frutarom acquisition ($7.1 billion) and the 2021 DuPont Nutrition & Biosciences merger (which created a combined company with an enterprise value of roughly $45.4 billion at the time) significantly broadened IFF's scale and pushed it into biosciences and functional ingredients beyond traditional flavors and fragrances, positioning it as one of a small handful of truly global players (alongside Givaudan and dsm-firmenich) able to serve multinational consumer goods companies everywhere they operate.

That said, IFF has spent the past several years simplifying a business that became overly complex and leveraged after the DuPont merger, divesting Pharma Solutions, its legacy Savory Solutions/flavors unit, and Lucas Meyer Cosmetics to sharpen focus and reduce debt — a sign that integration and portfolio complexity have been real challenges. Key risks include input-cost inflation (many raw materials are agricultural or petrochemical-derived and subject to price swings), regulatory and legal exposure around ingredient safety (IFF has settled lawsuits tied to diacetyl exposure in butter flavorings, for instance, and faces periodic environmental complaints near manufacturing sites), ongoing antitrust scrutiny in the flavor/fragrance industry, and the general risk that large customers could in-source or shift share among IFF's handful of global competitors. Against that, IFF's diversified end markets (food, beverage, personal care, home care, health) and structural demand for its ingredients across everyday consumer products give it a relatively defensive, recurring-revenue business model, even as margins are sensitive to input costs and mix.